Trial Outcomes & Findings for Monitoring and Testing of Blood Pressure in Postpartum Women (NCT NCT05236725)
NCT ID: NCT05236725
Last Updated: 2026-03-19
Results Overview
Used to determine feasibility of remote blood pressure monitoring intervention (rBPM) in postpartum women. This measure represents the median number of remote blood pressure monitoring (rBPM) measurements collected per participant during the study period. The total number of rBPM readings obtained for each participant was calculated, and the median value across all participants in the analysis population was reported
COMPLETED
NA
1607 participants
Discharge through Week 3 postpartum
2026-03-19
Participant Flow
All women, 18 years of age and older, who have delivered or are planning to deliver an infant(s) at The Birth Center at Atrium Health Wake Forest Baptist and reside in Forsyth County will be eligible for enrollment and invited to participate in the SMART-BP study. We enrolled women during the prenatal period from the Atrium Health Wake Forest Baptist Obstetrics clinics as well as after delivery. Enrollment period was 3/1/2022 through 8/30/2024
Participant milestones
| Measure |
Standard of Care (SOC)
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or Atrium Health Wake Forest Baptist Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Overall Study
STARTED
|
833
|
774
|
|
Overall Study
COMPLETED
|
797
|
728
|
|
Overall Study
NOT COMPLETED
|
36
|
46
|
Reasons for withdrawal
| Measure |
Standard of Care (SOC)
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or Atrium Health Wake Forest Baptist Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Overall Study
Subjects had a fetal demise
|
0
|
3
|
|
Overall Study
Subjects delivered and received postpartum at an outside facility
|
16
|
15
|
|
Overall Study
Subjects did not reside in Forsyth County North Carolina at the time of delivery
|
3
|
4
|
|
Overall Study
Subjects had duplicate enrollments
|
8
|
1
|
|
Overall Study
Subjects did not have daily access to a smartphone and/or available Wifi or data plan
|
0
|
7
|
|
Overall Study
Subjects that inaccurately reported age at time of enrollment
|
0
|
1
|
|
Overall Study
Subjects that enrolled during their second pregnancy during the study period
|
8
|
15
|
|
Overall Study
Death
|
1
|
0
|
Baseline Characteristics
Monitoring and Testing of Blood Pressure in Postpartum Women
Baseline characteristics by cohort
| Measure |
Standard of Care (SOC)
n=797 Participants
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
Total
n=1525 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
30.3 years
STANDARD_DEVIATION 6.06 • n=110 Participants
|
30.1 years
STANDARD_DEVIATION 5.89 • n=114 Participants
|
30.2 years
STANDARD_DEVIATION 6.00 • n=224 Participants
|
|
Sex: Female, Male
Female
|
797 Participants
n=110 Participants
|
728 Participants
n=114 Participants
|
1525 Participants
n=224 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=110 Participants
|
0 Participants
n=114 Participants
|
0 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Ethnicity: Hispanic or Latino
|
257 Participants
n=110 Participants
|
229 Participants
n=114 Participants
|
486 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Ethnicity: Not Hispanic or Latino
|
480 Participants
n=110 Participants
|
446 Participants
n=114 Participants
|
926 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Ethnicity: Prefer not to say
|
27 Participants
n=110 Participants
|
26 Participants
n=114 Participants
|
53 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: Prefer to self-describe
|
14 Participants
n=110 Participants
|
11 Participants
n=114 Participants
|
25 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Ethnicity: Some other race, ethnicity or origin
|
21 Participants
n=110 Participants
|
16 Participants
n=114 Participants
|
37 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Ethnicity: Unknown or not reported/missing
|
12 Participants
n=110 Participants
|
11 Participants
n=114 Participants
|
23 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: American Indian or Alaska Native
|
6 Participants
n=110 Participants
|
5 Participants
n=114 Participants
|
11 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: AsIan
|
23 Participants
n=110 Participants
|
13 Participants
n=114 Participants
|
36 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: Native Hawaiian or Other Pacific Islander
|
3 Participants
n=110 Participants
|
1 Participants
n=114 Participants
|
4 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: Black or African American
|
188 Participants
n=110 Participants
|
178 Participants
n=114 Participants
|
366 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: White
|
286 Participants
n=110 Participants
|
301 Participants
n=114 Participants
|
587 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: More than one race
|
31 Participants
n=110 Participants
|
18 Participants
n=114 Participants
|
49 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: Prefer not to say
|
90 Participants
n=110 Participants
|
72 Participants
n=114 Participants
|
162 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: Some other race, ethnicity, or origin
|
144 Participants
n=110 Participants
|
118 Participants
n=114 Participants
|
262 Participants
n=224 Participants
|
|
Race/Ethnicity, Customized
Race · Race: Unknown or not reported/missing
|
12 Participants
n=110 Participants
|
11 Participants
n=114 Participants
|
23 Participants
n=224 Participants
|
PRIMARY outcome
Timeframe: Discharge through Week 3 postpartumPopulation: Remote blood pressure monitoring was not implemented as part of usual care in the Standard of Care (SOC) arm. Participants assigned to the SOC arm did not receive remote BP devices, and no remote BP measurements were collected from this group. Therefore, no data for this outcome are available for SOC participants
Used to determine feasibility of remote blood pressure monitoring intervention (rBPM) in postpartum women. This measure represents the median number of remote blood pressure monitoring (rBPM) measurements collected per participant during the study period. The total number of rBPM readings obtained for each participant was calculated, and the median value across all participants in the analysis population was reported
Outcome measures
| Measure |
Standard of Care (SOC)
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Median Number of Remote Blood Pressure (rBPM) Measurements Obtained Per Participant
|
—
|
6 Number of rBPM measurements
Interval 0.0 to 22.0
|
PRIMARY outcome
Timeframe: Discharge through Day 10 postpartumThis outcome measures the proportion of participants whose postpartum blood pressure monitoring adhered to American College of Obstetricians and Gynecologists (ACOG) recommendations. Adherence includes: Initial Monitoring (first 72 hours postpartum): inpatient or equivalent monitoring for women with pregnancy-related hypertension; and Early Follow-Up (3-10 days postpartum): documentation of a follow-up visit or remote blood pressure check within 3-10 days after hospital discharge. Monitoring data will be obtained from electronic health records and remote blood pressure monitoring logs. Participants are counted once if they met both ACOG-recommended monitoring intervals.
Outcome measures
| Measure |
Standard of Care (SOC)
n=797 Participants
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Proportion of Participants Monitoring Blood Pressure (BP) According to American College of Obstetricians and Gynecologists (ACOG) Guidelines
|
0.308 Proportion of participants
|
0.786 Proportion of participants
|
PRIMARY outcome
Timeframe: From discharge through week 8 postpartumPopulation: There were 190 subjects in the SOC group and 157 subjects in the rBPM group that did not have total medical cost data available.
Cost of hospital based medical care of subjects in US dollars.
Outcome measures
| Measure |
Standard of Care (SOC)
n=607 Participants
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=571 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Median Total Cost of Health Care
|
1040 US dollars
Interval 402.0 to 2510.0
|
1046 US dollars
Interval 432.0 to 3386.0
|
PRIMARY outcome
Timeframe: Discharge through week 1 postpartumThis measure captures the number of participants who experienced one or more days in which a severe hypertension event occurred. A participant is counted once if they had ≥1 day meeting severe hypertension criteria, regardless of the total number of qualifying days. A severe or critical hypertensive event is defined as any blood pressure reading in which the systolic value is ≥160 mmHg and/or the diastolic value is ≥110 mmHg.
Outcome measures
| Measure |
Standard of Care (SOC)
n=797 Participants
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Number of Participants Experiencing at Least One Day With a Severe Hypertension Event
Number of participants having 1 or more severe systolic hypertensive events in a day
|
22 Number of participants
Interval 0.0 to 0.0
|
27 Number of participants
Interval 0.0 to 0.0
|
|
Number of Participants Experiencing at Least One Day With a Severe Hypertension Event
Number of participants having 1 or more severe diastolic hypertensive events in a day
|
4 Number of participants
Interval 0.0 to 0.0
|
34 Number of participants
Interval 0.0 to 0.0
|
PRIMARY outcome
Timeframe: Discharge through week 3 postpartumThis measure captures the number of participants who experienced one or more days in which a severe hypertension event occurred. A participant is counted once if they had ≥1 day meeting severe hypertension criteria, regardless of the total number of qualifying days. A severe or critical hypertensive event is defined as any blood pressure reading in which the systolic value is ≥160 mmHg and/or the diastolic value is ≥110 mmHg.
Outcome measures
| Measure |
Standard of Care (SOC)
n=797 Participants
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Number of Participants Experiencing at Least One Day With a Severe Hypertension Event
Number of participants with severe systolic hypertensive events
|
35 Number of participants
Interval 0.0 to 0.0
|
66 Number of participants
Interval 0.0 to 0.0
|
|
Number of Participants Experiencing at Least One Day With a Severe Hypertension Event
Number of participants with severe diastolic hypertensive events
|
10 Number of participants
Interval 0.0 to 0.0
|
50 Number of participants
Interval 0.0 to 0.0
|
PRIMARY outcome
Timeframe: Discharge through week 3 postpartumThe study team will use the electronic health record (EHR) to identify the number of participants who had one or more encounters at Emergency Department, Obstetric Triage, or Urgent Care facilities affiliated with Atrium Health Wake Forest Baptist. Encounters will be identified using visit type classifications and associated encounter codes documented in the EHR. Only encounters occurring within the specified study time frame and attributable to enrolled participants will be included. Each participant will be counted once regardless of the total number of urgent or emergent care visits they experienced.
Outcome measures
| Measure |
Standard of Care (SOC)
n=797 Participants
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 Participants
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
Number of Participants With One or More Urgent or Emergent Care Encounters
|
95 Number of subjects
|
131 Number of subjects
|
SECONDARY outcome
Timeframe: Discharge through week 8 postpartumStudy team will use the electronic health record to identify encounters to the Emergency Department, OB Triage, and Urgent Care facilities
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Week 3 postpartumSurvey to determine subject's level of satisfaction with use of the rBPM tools. Survey responses will be compared among subjects from varying demographic and socioeconomic groups. Survey is designed utilizing a Likert-type scale with 1-2 being higher level of acceptability, 3 being neutral, and 4-5 being lower level of acceptability of the rBPM tools. Study team will report the overall proportion and estimate the proportion of women with higher vs. lower levels of acceptability among women of different demographic and socioeconomic groups. This aim only applies to the women in the treatment (rBPM) arm.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Baseline (date of delivery) through discharge, assessed for up to 8 weeks postpartumOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Discharge through week 8 postpartumOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Discharge through week 8 postpartumOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Discharge through 12 months postpartumOutcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Discharge through week 8 postpartumIntended to assess the performance of the predictive algorithm in identifying postpartum high blood pressure readmissions. Study team will utilize blood pressure measures obtained through 3 weeks postpartum, as well as any hypertensive disorders of pregnancy events postpartum through 8 weeks postpartum, to include Emergency Department/Urgent Care/Obstetrics Triage encounters and any readmissions. The predictive algorithm is informed by information documented in the electronic health record, prior to delivery and during pregnancy.
Outcome measures
Outcome data not reported
Adverse Events
Standard of Care (SOC)
Remote Blood Pressure Monitoring (rBPM)
Serious adverse events
| Measure |
Standard of Care (SOC)
n=797 participants at risk
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 participants at risk
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
General disorders
Hospital readmission
|
3.3%
26/797 • Number of events 26 • All adverse events excluding severe hypertensive events were assessed from the time of hospital discharge through 8 weeks (56 days) postpartum. For severe hypertensive events, systolic and diastolic blood pressure measurements were evaluated from discharge through 3 weeks (21 days) postpartum.
|
4.7%
34/728 • Number of events 35 • All adverse events excluding severe hypertensive events were assessed from the time of hospital discharge through 8 weeks (56 days) postpartum. For severe hypertensive events, systolic and diastolic blood pressure measurements were evaluated from discharge through 3 weeks (21 days) postpartum.
|
Other adverse events
| Measure |
Standard of Care (SOC)
n=797 participants at risk
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
|
Remote Blood Pressure Monitoring (rBPM)
n=728 participants at risk
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring:
* a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2)
* BP monitoring smart phone app, BabyScripts™
* Verbal and written instructions, to conduct BP checks at home
|
|---|---|---|
|
General disorders
Hypertension
|
5.6%
45/797 • Number of events 57 • All adverse events excluding severe hypertensive events were assessed from the time of hospital discharge through 8 weeks (56 days) postpartum. For severe hypertensive events, systolic and diastolic blood pressure measurements were evaluated from discharge through 3 weeks (21 days) postpartum.
|
15.9%
116/728 • Number of events 153 • All adverse events excluding severe hypertensive events were assessed from the time of hospital discharge through 8 weeks (56 days) postpartum. For severe hypertensive events, systolic and diastolic blood pressure measurements were evaluated from discharge through 3 weeks (21 days) postpartum.
|
Additional Information
Elizabeth T. Jensen, MPH PhD, Professor of Epidemiology
Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place